Holen Sie sich die Stockscreener-App
4.11
4.05%
0.16
Schlusskurs vom Vortag:
$3.95
Offen:
$4.05
24-Stunden-Volumen:
5.44M
Relative Volume:
2.77
Marktkapitalisierung:
$582.98M
Einnahmen:
$288.95M
Nettoeinkommen (Verlust:
$-119.03M
KGV:
-4.5641
EPS:
-0.9005
Netto-Cashflow:
$60.67M
1W Leistung:
-2.14%
1M Leistung:
-21.41%
6M Leistung:
-53.19%
1J Leistung:
-21.86%
1-Tages-Spanne:
$3.93
$4.30
1-Wochen-Bereich:
$3.93
$4.40
52-Wochen-Spanne:
$3.93
$11.55
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Firmenname
Maravai Lifesciences Holdings Inc
Sektor
Branche
Telefon
(858) 546-0004
Adresse
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Vergleichen Sie MRVI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
4.11 | 582.98M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-19 | Eingeleitet | Guggenheim | Neutral |
| 2024-12-05 | Herabstufung | Goldman | Neutral → Sell |
| 2024-11-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-08 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | Eingeleitet | Craig Hallum | Buy |
| 2023-12-12 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-08-08 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | Herabstufung | Goldman | Buy → Neutral |
| 2023-01-05 | Herabstufung | UBS | Buy → Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-11-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Eingeleitet | BofA Securities | Buy |
| 2020-12-15 | Eingeleitet | Credit Suisse | Outperform |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-15 | Eingeleitet | Jefferies | Buy |
| 2020-12-15 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-12-15 | Eingeleitet | Stifel | Buy |
| 2020-12-15 | Eingeleitet | William Blair | Outperform |
| 2020-12-14 | Eingeleitet | UBS | Buy |
Alle ansehen
Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten
Maravai LifeSciences (NASDAQ:MRVI) Hits New 1-Year LowHere's What Happened - MarketBeat
Investors Purchase High Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - Armenian Reporter
Maravai LifeSciences (MRVI) Projected to Post Quarterly Earnings on Thursday - Defense World
Maravai LifeSciences Target of Unusually High Options Trading (NASDAQ:MRVI) - Defense World
Maravai LifeSciences (MRVI) to Release Quarterly Earnings on Thursday - MarketBeat
MRVI stock touches 52-week low at $4.04 amid market challenges By Investing.com - Investing.com South Africa
MRVI stock touches 52-week low at $4.04 amid market challenges - Investing.com
Choreo LLC Sells 26,716 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Maravai LifeSciences (NASDAQ:MRVI) Sets New 12-Month LowTime to Sell? - MarketBeat
Maravai Lifesciences stock hits 52-week low at $4.19 - MSN
Bleakley Financial Group LLC Grows Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Reviewing Maravai LifeSciences (NASDAQ:MRVI) and MBX Biosciences (NYSE:MBX) - Defense World
Maravai LifeSciences (NASDAQ:MRVI) Stock Price Down 6.5%Here's Why - MarketBeat
Market Highlights: Maravai LifeSciences Holdings Inc (MRVI) Ends on a Low Note at 4.58 - The Dwinnex
Maravai LifeSciences (NASDAQ:MRVI) & MBX Biosciences (NYSE:MBX) Critical Comparison - Armenian Reporter
It is Poised to be a Bull Market for Maravai LifeSciences Holdings Inc (MRVI) - SETE News
Investors Purchase Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - MarketBeat
Positive Sentiment Still Eludes Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Following 25% Share Price Slump - Simply Wall St
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Rating of "Hold" by Analysts - MarketBeat
A Look at Maravai LifeSciences Holdings Inc (MRVI) Shares in the Recent Past Indicates Growth - SETE News
Stock Traders Purchase Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Consensus Rating of “Hold” by Analysts - ETF Daily News
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of “Hold” by Brokerages - Defense World
Understanding the 8.92% Volatility Levels of Maravai LifeSciences Holdings Inc’s (MRVI) Stock in the Past 30 Days - The News Heater
TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology - Marketscreener.com
Breakthrough mRNA Deal: TriLink's CleanCap Tech Powers Next-Gen Clinical Development at Aldevron - StockTitan
Maravai LifeSciences Holdings Inc (MRVI) receives a Neutral rating from Guggenheim - Knox Daily
Maravai LifeSciences Holdings Inc’s results are impressive - US Post News
Ratio Analysis: Unpacking Maravai LifeSciences Holdings Inc (MRVI)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Insider Selling: Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) General Counsel Sells 25,000 Shares of Stock - MarketBeat
Sivik Global Healthcare LLC Cuts Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe - Yahoo Finance
Maravai LifeSciences (NASDAQ:MRVI) Stock Price Down 7.1%Should You Sell? - MarketBeat
Press Release Service: Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies - CRISPR Medicine News
Maravai LifeSciences expands mRNA manufacturing with new acquisition By Investing.com - Investing.com Australia
Maravai Lifesciences Acquires Molecular Assemblies' Intellectual Property, Related Assets - Marketscreener.com
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies - Business Wire
12 West Capital Management LP Reduces Stake in Maravai LifeSciences Holdings Inc - GuruFocus.com
Game-Changing DNA Synthesis Tech Could Revolutionize CRISPR Therapy Production - StockTitan
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI) - MarketBeat
Traders Purchase Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - Defense World
Maravai LifeSciences (NASDAQ:MRVI) Stock Price Up 9.5%Here's Why - MarketBeat
Maravai LifeSciences Holdings, Inc. (MRVI) Stock: An Under $5 Gem with Biggest Upside Potential - Yahoo Finance
12 Stocks Under $5 With Biggest Upside Potential - Insider Monkey
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap UpTime to Buy? - MarketBeat
Are Investors Undervaluing Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) By 43%? - Simply Wall St
Finanzdaten der Maravai Lifesciences Holdings Inc-Aktie (MRVI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):